Belgian registry for heart infections
Part of Heart & circulation clinical trials.
This study is a registry, meaning it collects information about people who have had endocarditis (an infection of the heart's inner lining or valves). By joining, you help researchers learn more about this condition and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gathers information from patients with a heart infection called endocarditis to help doctors better understand and treat the condition. Anyone aged 16 or older with confirmed or suspected endocarditis who is being treated at Barts Heart Centre may be able to join.
This trial is a national hospital registry that collects information from people hospitalized with suspected infective endocarditis (an infection of the heart lining or valves). It may help doctors better classify cases and improve care by analyzing real-world patient data.
This is an observational study that follows people with confirmed infective endocarditis (a serious infection of the heart lining or heart valves). It may help doctors better understand the illness and improve care.
This study collects information from people who have surgery for an infection in their heart (endocarditis). By looking at many patients across Europe, doctors hope to learn better ways to treat this condition.
This study looks at blood and other lab test results (“biomarkers”) to better predict what may happen to people with infective endocarditis, a serious infection of the heart lining or heart valves. Your information may help doctors estimate risk and choose care more safely and effectively.
This trial measures how your body handles certain intravenous antibiotics used for endocarditis, an infection of the heart valves. It may help doctors understand the best antibiotic dosing for people with valve infections.
Hear when a new Infective Endocarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.